|Bid||11.08 x 1300|
|Ask||11.95 x 800|
|Day's Range||11.10 - 11.63|
|52 Week Range||7.40 - 18.93|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CARA
Cara (CARA) delivered earnings and revenue surprises of 71.43% and 8.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
In this article, we discuss 10 medical marijuana stocks to buy now. If you want to see more stocks in this list, check out 5 Medical Marijuana Stocks to Buy Now. Medical Marijuana, also called medical Cannabis, is a herbal drug derived from plants of the genus Cannabis that is used as part of the […]